DEPARTMENT OF DEFENSE - CONGRESSIONALLY DIRECTED MEDICAL RESEARCH PROGRAMS
  1. Home
  2. Funding Opportunities
  3. Synopsis of Open Program Funding Opportunities

Funding Opportunities

Synopsis of Open Program Funding Opportunities



FY20 Breast Cancer Research Program (BCRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Breakthrough Award Levels 1 and 2 Program Announcement
Application Instructions
 April 30, 2020 Funding Level 1:
  • Maximum funding of $450,000 for direct costs (plus indirect costs).
  • The maximum period of performance is 3 years.

Funding Level 1 with Partnering PI Option:

  • Maximum funding of $750,000 for direct costs (plus indirect costs).
  • The maximum period of performance is 3 years.

Funding Level 2:

  • Maximum funding of $1 million (M) for direct costs (plus indirect costs).
  • The maximum period of performance is 3 years.

Funding Level 2 with Partnering PI Option:

  • Maximum funding of $1.5M for direct costs (plus indirect costs).
  • The maximum period of performance is 3 years.

Funding Level 2 – Population Science and Prevention Studies:

  • Maximum funding of $1.5M for direct costs (plus indirect costs).
  • The maximum period of performance is 4 years.

Funding Level 2 – Population Science and Prevention Studies – Partnering PI Option:

  • Maximum funding of $2M for direct costs (plus indirect costs).
  • The maximum period of performance is 4 years.
 Pre-Application (Letter of Intent): September 8, 2020

Application: September 22, 2020
Era of Hope Scholar Award Program Announcement
Application Instructions
 April 30, 2020
  • Maximum funding of $3M for direct costs (plus indirect costs).
  • The maximum period of performance is 4 years.
 Pre-Application (Letter of Intent): September 8, 2020

Application: September 22, 2020

Confidential Letters of Recommendation Submission Deadline: September 25, 2020


FY20 Chronic Pain Management Research Program (CPMRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Investigator-Initiated Research Award Program Announcement
Application Instructions 		June 18, 2020
  • The maximum allowable funding for the entire period of performance is $900,000 for direct costs.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
  • The maximum period of performance is 4 years.
 Pre-Application (Preproposal):
August 7, 2020

Application:
November 6, 2020
Translational Research Award Program Announcement
Application Instructions 		June 18, 2020
  • The maximum allowable funding for the entire period of performance is $1,400,000 for direct costs.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
  • The maximum period of performance is 4 years.
 Pre-Application (Preproposal):
August 7, 2020

Application:
November 6, 2020

FY20 Duchenne Muscular Dystrophy Research Program (DMDRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Idea Development Award Program Announcement
Application Instructions 		May 28, 2020
  • Maximum funding of $350,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 2 years.
 Pre-Application:
August 12, 2020

Preproposal is required; application submission is by invitation only.

Application:
December 7, 2020
Translational Research Partnership Award Program Announcement
Application Instructions 		May 28, 2020
  • Maximum funding of $1,200,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 3 years.
 Pre-Application:
August 12, 2020

Preproposal is required; application submission is by invitation only.

Application:
December 7, 2020

FY20 Hearing Restoration Research Program (HRRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Focused Research Award (FRA) Program Announcement
Application Instructions 		May 7, 2020 Funding Level 1:
  • Maximum funding of $250,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 2 years.
 Funding Level 2:
  • Maximum funding of $1,000,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 3 years.
 Funding Level 2 with Pilot Clinical Trial Option:
  • Maximum funding of $1,250,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 3 years.
 Pre-Application (Preproposal):
July 14, 2020

Application:
November 3, 2020

FY20 Kidney Cancer Research Program (KCRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Academy of Kidney Cancer Investigators – Early Career Investigator Award Program Announcement
Application Instructions 		May 12, 2020
  • Maximum funding of $725,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 4 years.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
 Pre-Application (Letter of Intent):
August 5, 2020

Application:
August 26, 2020
Concept Award Program Announcement
Application Instructions 		May 12, 2020
  • Maximum funding of $100,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 1 year.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
 Pre-Application (Letter of Intent):
July 15, 2020

Application:
August 5, 2020
Translational Research Partnership Award Program Announcement
Application Instructions 		May 12, 2020
  • Maximum funding of $750,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 3 years.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
 Pre-Application (Letter of Intent):
August 5, 2020

Application:
August 26, 2020
Clinical Consortium – Clinical Trial Site Award Program Announcement
Application Instructions 		June 3, 2020 Clinical Trial Sites
  • Maximum funding of $600,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 2 years.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
 Pre-Application (Letter of Intent):
September 2, 2020

Application:
September 23, 2020
Idea Development Award Program Announcement
Application Instructions 		June 4, 2020
  • Maximum funding of $600,000 in direct costs (plus indirect costs).
  • Period of performance not to exceed 3 years.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
Early Detection Studies Option:
  • Maximum funding of $650,000 in direct costs (plus indirect costs).
  • Period of performance not to exceed 3 years.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
Population Science and Prevention Studies Option:
  • Maximum funding of $2 million in direct costs (plus indirect costs).
  • Period of performance not to exceed 4 years.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
 Pre-Application (Letter of Intent):
September 2, 2020

Application:
September 23, 2020
Postdoctoral and Clinical Fellowship Award Program Announcement
Application Instructions 		June 3, 2020
  • Maximum funding of $195,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 3 years.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate.
 Pre-Application (Letter of Intent):
September 2, 2020

Application:
September 23, 2020


FY20 Lung Cancer Research Program (LCRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Career Development Award Program Announcement
Application Instructions
 Updated May 6, 2020
  • Maximum funding of $250,000 in direct costs (plus indirect costs).
  • Period of performance not to exceed 2 years.
 Pre-Application (Letter of Intent):
July 22, 2020

Letter of Intent is required.

Application: August 5, 2020
Clinical Translational Research Partnership Award Program Announcement
Application Instructions
 Updated May 6, 2020
  • Maximum combined funding of $1,200,000 in direct costs (plus indirect costs).
  • Period of performance not to exceed 3 years.
 Pre-Application (Letter of Intent):
July 22, 2020

Letter of Intent is required.

Application: August 5, 2020


LRP

FY20 Lupus Research Program (LRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Idea Award Program Announcement
Application Instructions
 May 29, 2020
  • The maximum period of performance is 2 years.
  • The maximum allowable funding for the entire period of performance is $300,000 in total costs.
 Pre-Application (Letter of Intent): August 25, 2020

Application: September 23, 2020
Impact Award Program Announcement
Application Instructions
 May 29, 2020
  • The maximum period of performance is 4 years.
  • The maximum allowable funding for the entire period of performance is $750,000 in total costs.
 Pre-Application (Letter of Intent): August 25, 2020

Application: September 23, 2020
Transformative Vision Award Program Announcement
Application Instructions
 May 29, 2020
  • The maximum period of performance is 4 years.
  • The maximum allowable funding for the entire period of performance is $2,500,000 in total costs.
 Pre-Application (Letter of Intent): August 25, 2020

Application: September 23, 2020


FY20 Neurotoxin Exposure Treatment Parkinson’s Research Program (NETP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Early Investigator Research Award Program Announcement
Application Instructions 		May 7, 2020
  • Maximum funding of $400,000 for total costs (includes direct and indirect costs).
  • Maximum period of performance is 2 years.
 Pre-Application (Letter of Intent):
August 18, 2020

Application:
September 16, 2020
Investigator-Initiated Research Award Program Announcement
Application Instructions 		May 7, 2020
  • Maximum funding of $1.2 million (M) for total costs (includes direct and indirect costs).
  • Maximum Period of performance is 3 years.
 Pre-Application (Letter of Intent):
August 18, 2020

Application:
September 16, 2020
Synergistic Idea Award Program Announcement
Application Instructions 		May 7, 2020
  • Maximum funding of $3 million (M) for total costs (includes direct and indirect costs).
  • Maximum Period of performance is 4 years.
 Pre-Application (Letter of Intent):
August 18, 2020

Application:
September 16, 2020


FY20 Orthotics and Prosthetics Outcomes Research Program (OPORP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Clinical Research Award (CRA) Program Announcement
Application Instructions
 March 31, 2020 The FY20 CRA offers two funding levels: Funding Level 1:
  • Maximum funding of $350,000 for total costs (direct costs plus indirect costs).
  • Maximum period of performance is 2 years.
Funding Level 2:
  • Maximum funding of $2,000,000 for total costs (direct costs plus indirect costs).
  • Maximum period of performance is 4 years.
 Pre-Application (Letter of Intent):
July 15, 2020

Application:
July 29, 2020
Clinical Trial Award (CTA) Program Announcement
Application Instructions
 March 31, 2020 The FY20 CTA offers two funding levels: Funding Level 1:
  • Maximum funding of $350,000 for total costs (direct costs plus indirect costs).
  • Maximum period of performance is 2 years.
Funding Level 2:
  • Maximum funding of $4,000,000 for total costs (direct costs plus indirect costs).
  • Maximum period of performance is 4 years.
 Pre-Application (Letter of Intent):
July 15, 2020

Application:
July 29, 2020

FY20 Ovarian Cancer Research Program (OCRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Proteogenomics Research Award Program Announcement
Application Instructions 		April 2, 2020
  • Maximum funding of $250,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 2 years.
 Pre-Application:
July 16, 2020

Application:
July 30, 2020


FY20 Peer Reviewed Cancer Research Program (PRCRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Virtual Cancer Center Director Award Program Announcement
Application Instructions 		March 23, 2020
  • Maximum funding for the entire period of performance is $1,250,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 4 years.
 Pre-Application (Letter of Intent):
July 30, 2020

Application: August 20, 2020
Career Development Award - Fellow Option Program Announcement
Application Instructions 		March 23, 2020
  • Maximum funding for the entire period of performance is $400,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 3 years.
 Pre-Application (Letter of Intent):
July 30, 2020

Application: August 20, 2020
Career Development Award – Virtual Cancer Center Scholar Option Program Announcement
Application Instructions 		March 23, 2020
  • Maximum funding for the entire period of performance is $800,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 4 years.
 Pre-Application (Letter of Intent):
July 30, 2020

Application: August 20, 2020
Behavioral Health Science Award Program Announcement
Application Instructions 		March 23, 2020
  • Maximum funding for the entire period of performance is $1,000,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 4 years.
 Pre-Application (Letter of Intent):
July 30, 2020

Application: August 27, 2020
Translational Team Science Award Program Announcement
Application Instructions 		March 23, 2020
  • Maximum funding for the entire period of performance is $1,500,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 4 years.
 Pre-Application (Letter of Intent):
July 30, 2020

Application: August 27, 2020

FY20 Peer Reviewed Medical Research Program (PRMRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Clinical Trial Award Program Announcement
Application Instructions 		April 8, 2020 Planning Phase (optional):
Maximum of $500,000 for direct costs (plus indirect costs).

Maximum period of performance is 18 months.

Clinical Trial:
No maximum funding limit; requested funding must be appropriate for the scope of work proposed.

Maximum period of performance is 4 years.

 Pre-Application (Letter of Intent): July 29, 2020

Application: August 13, 2020




FY20 Peer Reviewed Orthopaedic Research Program (PRORP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Applied Research Award (ARA) Program Announcement
Application Instructions 		March 16, 2020
  • Maximum funding of $725,000 for total costs (includes direct and indirect costs).
  • Maximum period of performance is 3 years.
 Pre-Application (Preproposal):
May 27, 2020

Application:
September 10, 2020
Clinical Trial Award (CTA) Program Announcement
Application Instructions 		March 16, 2020 Funding Level 1:
  • Maximum funding of $2.25 million (M) for total costs (includes direct and indirect costs).
  • Maximum period of performance is 4 years.
Funding Level 2: (Translation of Early Findings – Soft Tissue Trauma Focus Area with Rehabilitation Option):
  • Maximum funding of $2.75 million (M) for total costs (includes direct and indirect costs).
  • Maximum period of performance is 4 years.
 Pre-Application (Preproposal):
May 27, 2020

Application:
September 10, 2020
Clinical Translational Research Award (CTRA) Program Announcement
Application Instructions 		March 16, 2020
  • Maximum funding of $1.5 million (M) for total costs (includes direct and indirect costs).
  • Maximum period of performance is 4 years.
 Pre-Application (Preproposal):
May 27, 2020

Application:
September 10, 2020


FY20 Prostate Cancer Research Program (PCRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Idea Development Award Program Announcement
Application Instructions 		April 7, 2020 Established Investigators:
  • Maximum funding of $750,000 for direct costs (plus indirect costs).

New Investigators:

  • Maximum funding of $600,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 3 years.
 Pre-application (Letter of Intent): August 27, 2020

Application: September 24, 2020
Prostate Cancer Pathology Resource Network Award Program Announcement
Application Instructions 		May 8, 2020
  • Maximum funding of $6,000,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 3 years.
 Pre-Application (Letter of Intent): September 10, 2020

Application: September 24, 2020

FY20 Vision Research Program (VRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Focused Translational Team Science Award (FTTSA) Program Announcement
Application Instructions 		May 20, 2020
  • Maximum funding of $5,000,000 for direct costs (plus indirect costs).
  • The maximum period of performance is 4 years.
 Pre-Application (Preproposal):
July 28, 2020

Application: November 18, 2020
Investigator-Initiated Research Award (IIRA) Program Announcement
Application Instructions 		May 20, 2020 Funding Level 1:
  • Maximum funding of $260,000 for direct costs (plus indirect costs).
  • The maximum period of performance is 2 years.
Funding Level 2:
  • Maximum funding of $750,000 for direct costs (plus indirect costs).
  • The maximum period of performance is 3 years.
 Pre-Application (Preproposal):
July 28, 2020

Application: November 18, 2020
Translational Research Award (TRA) Program Announcement
Application Instructions 		May 20, 2020
  • Maximum funding of $1,000,000 for direct costs (plus indirect costs).
  • The maximum period of performance is 3 years.
 Pre-Application (Preproposal):
July 28, 2020

Application: November 18, 2020

Last updated Friday, June 26, 2020